Research advance of Nrf2 on atherosclerosis by regulating vascular smooth muscle cell.
10.3724/zdxbyxb-2021-0190
- Author:
Wenwen ZHUANG
1
;
Yongqi YANG
1
;
Hongliang LI
1
;
Jingyan LIANG
1
Author Information
1. Institute of Translational Medicine.
- Publication Type:Review
- Keywords:
Atherosclerosis;
Nuclear factor-erythroid 2- related factor 2;
Review;
Vascular smooth muscle cell
- MeSH:
Atherosclerosis;
Cell Movement;
Cell Proliferation;
Cells, Cultured;
Humans;
Muscle, Smooth, Vascular;
Myocytes, Smooth Muscle;
NF-E2-Related Factor 2/metabolism*;
Signal Transduction
- From:
Journal of Zhejiang University. Medical sciences
2021;50(3):390-395
- CountryChina
- Language:English
-
Abstract:
Atherosclerosis is a common pathological change in cardiovascular disease. Vascular smooth muscle cell is the main source of plaque cell and extracellular matrix, and nuclear factor-erythroid 2-related factor 2 (Nrf2) is a key transcription factor regulating the function of vascular smooth muscle cell. In the process of atherosclerosis, Nrf2 signaling pathway has the following regulatory effects on vascular smooth muscle cell: regulating the phenotype of vascular smooth muscle cell to change to the direction conducive to the alleviation of disease progression; inhibiting the proliferation and migration of vascular smooth muscle cell; mitigating the level of blood lipid; alleviating vascular smooth muscle cell calcification, aging and apoptosis process. This article reviews the specific mechanisms of Nrf2 regulating atherosclerosis, such as phenotypic transformation, proliferation and migration, lipid metabolism, calcification, aging and apoptosis in atherosclerosis, in order to provide a basis for understanding the molecular mechanism of atherosclerosis development and finding therapeutic targets.
